Business Context and Reporting Period
Company: SELLAS Life Sciences Group, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: October 1, 2025
Reporting Period: Event date October 1, 2025; Signed October 3, 2025.
Key Financial Metrics
This filing does not contain revenue, profit, cash flow, margin, debt, or liquidity metrics. The document reports a specific corporate event rather than periodic financial performance.
Material Changes
Item 1.01 - Entry into a Material Definitive Agreement:
- Agreement: Letter Agreement entered into with Times Square Tower Associates LLC (Sublandlord).
- Subject: Extension of the sublease for premises at 7 Times Square, New York, NY.
- Term Change: Expiration date extended from September 30, 2026, to September 30, 2027.
- Financial Impact: Annual rent remains unchanged.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the standard incorporation of the Letter Agreement by reference.
Investor Verification Checklist
- Verify the full terms of the Letter Agreement filed as Exhibit 10.1.
- Confirm the total remaining lease obligation following the one-year extension.
- Assess the strategic necessity of the New York office space extension relative to current operational needs.